After detection of an SS18–SSX1 fusion, it became apparent that the large epithelial component with HER2 overexpression of this tumor was misinterpreted as an adenocarcinoma, and the diagnosis was revised to a synovial sarcoma. The gene discussed is ERBB2; the disease is adenocarcinoma.